Literature DB >> 31255586

Acceptance and Commitment Therapy for Symptom Interference in Advanced Lung Cancer and Caregiver Distress: A Pilot Randomized Trial.

Catherine E Mosher1, Ekin Secinti2, Adam T Hirsh2, Nasser Hanna3, Lawrence H Einhorn3, Shadia I Jalal4, Gregory Durm3, Victoria L Champion5, Shelley A Johns6.   

Abstract

CONTEXT: Advanced lung cancer patients typically have a poor prognosis and many symptoms that interfere with functioning, contributing to high rates of emotional distress in both patients and family caregivers. There remains a need for evidence-based interventions to improve functional outcomes and distress in this population.
OBJECTIVES: This pilot trial examined the feasibility and preliminary efficacy of telephone-based Acceptance and Commitment Therapy (ACT) for symptomatic, advanced lung cancer patients and their distressed family caregivers. Primary outcomes were patient symptom interference with functioning and patient and caregiver distress.
METHODS: Symptomatic, advanced lung cancer patients and distressed caregivers (n = 50 dyads) were randomly assigned to six sessions of ACT or an education/support condition. Patients completed measures of symptom interference and measures assessing the severity of fatigue, pain, sleep disturbance, and breathlessness. Patients and caregivers completed measures of distress and illness acceptance and struggle.
RESULTS: The eligibility screening rate (51%) and retention rate (76% at six weeks postintervention) demonstrated feasibility. No group differences were found with respect to patient and caregiver outcomes. Both groups showed a small, significant decrease in struggle with the illness over the study period, but did not show meaningful change in other outcomes.
CONCLUSION: Findings suggest that telephone-based ACT is feasible for many advanced lung cancer patients and caregivers, but may not substantially reduce symptom interference and distress. Low baseline levels of certain symptoms may have contributed to null findings. Next steps include applying ACT to specific, clinically meaningful symptom interference and varying intervention dose and modality.
Copyright © 2019 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acceptance and Commitment Therapy; Lung cancer; distress; family caregivers; psychosocial intervention; symptom management

Mesh:

Year:  2019        PMID: 31255586      PMCID: PMC6754796          DOI: 10.1016/j.jpainsymman.2019.06.021

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  10 in total

1.  Spirituality-Integrated Interventions for Caregivers of Patients with Terminal Illness: A Systematic Review of Quantitative Outcomes.

Authors:  Yongqiang Zheng; Anna Cox Cotton; Longtao He; Leslie Grace Wuest
Journal:  J Relig Health       Date:  2021-03-08

2.  Technology-supported Acceptance and Commitment Therapy for chronic health conditions: A systematic review and meta-analysis.

Authors:  Matthew S Herbert; Cara Dochat; Jennalee S Wooldridge; Karla Materna; Brian H Blanco; Mara Tynan; Michael W Lee; Marianna Gasperi; Angela Camodeca; Devon Harris; Niloofar Afari
Journal:  Behav Res Ther       Date:  2021-11-12

3.  Acceptance and commitment therapy for patient fatigue interference and caregiver burden in advanced gastrointestinal cancer: Results of a pilot randomized trial.

Authors:  Catherine E Mosher; Ekin Secinti; Wei Wu; Deborah A Kashy; Kurt Kroenke; Jonathan B Bricker; Paul R Helft; Anita A Turk; Patrick J Loehrer; Amikar Sehdev; Ahmad A Al-Hader; Victoria L Champion; Shelley A Johns
Journal:  Palliat Med       Date:  2022-05-30       Impact factor: 5.713

4.  Facets of stigma, self-compassion, and health-related adjustment to lung cancer: A longitudinal study.

Authors:  Timothy J Williamson; Edward B Garon; Jenessa R Shapiro; Denise A Chavira; Jonathan W Goldman; Annette L Stanton
Journal:  Health Psychol       Date:  2022-04       Impact factor: 5.556

5.  Study design and protocol for tailored Acceptance and Commitment Therapy (ACT) to optimize quality of life in women living with metastatic breast cancer.

Authors:  Patricia I Moreno; Fiona S Horner; Joanna B Torzewski; Jessica L Thomas; William Gradishar; David Victorson; Frank J Penedo
Journal:  Contemp Clin Trials Commun       Date:  2021-12-17

6.  Effects of Acceptance and Commitment Therapy on fatigue interference and health-related quality of life among patients with advanced lung cancer: A pilot randomized controlled trial.

Authors:  Huiyuan Li; Xiaohuan Jin; Marques Shek Nam Ng; Ka Fai Mann; Nina Wang; Cho Lee Wong
Journal:  Asia Pac J Oncol Nurs       Date:  2022-06-09

7.  Verifying intervention fidelity procedures for a palliative home care intervention with pilot study results.

Authors:  Ubolrat Piamjariyakul; Angel Smothers; Stephanie Young; Elizabeth Morrissey; Trisha Petitte; Sijin Wen; Rafia Zulfikar; Rahul Sangani; Saima Shafique; Carol E Smith; Kelly Bosak
Journal:  Res Nurs Health       Date:  2021-06-30       Impact factor: 2.238

8.  The Challenges of Enrollment and Retention: A Systematic Review of Psychosocial Behavioral Interventions for Patients With Cancer and Their Family Caregivers.

Authors:  Lixin Song; Yousef Qan'ir; Ting Guan; Peiran Guo; Shenmeng Xu; Ahrang Jung; Eno Idiagbonya; Fengyu Song; Erin Elizabeth Kent
Journal:  J Pain Symptom Manage       Date:  2021-04-30       Impact factor: 5.576

9.  The effect of acceptance and commitment therapy on insomnia and sleep quality: A systematic review.

Authors:  Nader Salari; Habibolah Khazaie; Amin Hosseinian-Far; Behnam Khaledi-Paveh; Hooman Ghasemi; Masoud Mohammadi; Shamarina Shohaimi
Journal:  BMC Neurol       Date:  2020-08-13       Impact factor: 2.474

Review 10.  Mindfulness-Based Programs for Patients With Cancer via eHealth and Mobile Health: Systematic Review and Synthesis of Quantitative Research.

Authors:  Juraj Matis; Miroslav Svetlak; Alena Slezackova; Marek Svoboda; Rastislav Šumec
Journal:  J Med Internet Res       Date:  2020-11-16       Impact factor: 5.428

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.